121 results
DEFA14A
RLAY
Relay Therapeutics Inc
23 Apr 24
Additional proxy soliciting materials
4:10pm
officers; 3. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31
S-8
RLAY
Relay Therapeutics Inc
22 Feb 24
Registration of securities for employees
4:34pm
on February 22, 2024).
Opinion of Goodwin Procter LLP
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
Consent of Goodwin Procter
S-8
EX-5.1
RLAY
Relay Therapeutics Inc
22 Feb 24
Registration of securities for employees
4:34pm
and made such examination of law as we have deemed appropriate to give the opinions set forth below. We have relied, without independent verification
S-8
EX-23.1
44kg7
22 Feb 24
Registration of securities for employees
4:34pm
424B7
t0khm81
10 Jan 24
Prospectus with selling stockholder info
9:22am
8-K
EX-99.1
bj03ebl6lz8kybna39
8 Jan 24
Entry into a Material Definitive Agreement
7:05am
8-K
EX-10.1
wn6wjh32k9zw2u7
8 Jan 24
Entry into a Material Definitive Agreement
7:05am
424B7
39eh75trh sjxgpu00
16 Nov 23
Prospectus with selling stockholder info
4:16pm
8-K
EX-99.2
2ldvhvxvr sya
12 Oct 23
Relay Therapeutics Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across Multiple FGFR2-Altered Solid Tumors
4:13pm
8-K
EX-99.2
wuf5nyc5joj7n1kn3tbv
8 Aug 23
Relay Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Highlights
4:14pm
8-K
41pru
31 May 23
Submission of Matters to a Vote of Security Holders
4:05pm
DEFA14A
coj 1oe73ua
21 Apr 23
Additional proxy soliciting materials
4:04pm